NM_015166.4:c.*45A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015166.4(MLC1):​c.*45A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 1,582,736 control chromosomes in the GnomAD database, including 14,708 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1772 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12936 hom. )

Consequence

MLC1
NM_015166.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.53

Publications

12 publications found
Variant links:
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 22-50061538-T-C is Benign according to our data. Variant chr22-50061538-T-C is described in ClinVar as Benign. ClinVar VariationId is 260572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLC1NM_015166.4 linkc.*45A>G 3_prime_UTR_variant Exon 12 of 12 ENST00000311597.10 NP_055981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLC1ENST00000311597.10 linkc.*45A>G 3_prime_UTR_variant Exon 12 of 12 1 NM_015166.4 ENSP00000310375.6
MLC1ENST00000395876.6 linkc.*45A>G 3_prime_UTR_variant Exon 12 of 12 1 ENSP00000379216.2
MLC1ENST00000483836.1 linkn.536A>G non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
22492
AN:
152122
Hom.:
1764
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.175
Gnomad AMI
AF:
0.142
Gnomad AMR
AF:
0.161
Gnomad ASJ
AF:
0.185
Gnomad EAS
AF:
0.192
Gnomad SAS
AF:
0.136
Gnomad FIN
AF:
0.0979
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.154
GnomAD2 exomes
AF:
0.144
AC:
35843
AN:
249526
AF XY:
0.142
show subpopulations
Gnomad AFR exome
AF:
0.177
Gnomad AMR exome
AF:
0.160
Gnomad ASJ exome
AF:
0.173
Gnomad EAS exome
AF:
0.195
Gnomad FIN exome
AF:
0.102
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.142
GnomAD4 exome
AF:
0.133
AC:
189574
AN:
1430494
Hom.:
12936
Cov.:
29
AF XY:
0.133
AC XY:
94650
AN XY:
713724
show subpopulations
African (AFR)
AF:
0.180
AC:
5890
AN:
32722
American (AMR)
AF:
0.160
AC:
7133
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
4479
AN:
25994
East Asian (EAS)
AF:
0.197
AC:
7772
AN:
39542
South Asian (SAS)
AF:
0.136
AC:
11670
AN:
85712
European-Finnish (FIN)
AF:
0.102
AC:
5263
AN:
51410
Middle Eastern (MID)
AF:
0.142
AC:
765
AN:
5384
European-Non Finnish (NFE)
AF:
0.127
AC:
138356
AN:
1085676
Other (OTH)
AF:
0.139
AC:
8246
AN:
59382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8980
17959
26939
35918
44898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5054
10108
15162
20216
25270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.148
AC:
22530
AN:
152242
Hom.:
1772
Cov.:
33
AF XY:
0.148
AC XY:
10985
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.174
AC:
7248
AN:
41538
American (AMR)
AF:
0.162
AC:
2472
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.185
AC:
643
AN:
3472
East Asian (EAS)
AF:
0.192
AC:
994
AN:
5168
South Asian (SAS)
AF:
0.136
AC:
654
AN:
4822
European-Finnish (FIN)
AF:
0.0979
AC:
1039
AN:
10618
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8974
AN:
68012
Other (OTH)
AF:
0.162
AC:
342
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
993
1986
2979
3972
4965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
305
Bravo
AF:
0.155
Asia WGS
AF:
0.173
AC:
604
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.59
DANN
Benign
0.52
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072873; hg19: chr22-50499967; COSMIC: COSV61119233; COSMIC: COSV61119233; API